Nan Shan Life Insurance Co. Ltd. Purchases New Shares in UnitedHealth Group Incorporated (NYSE:UNH)

Nan Shan Life Insurance Co. Ltd. purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 175,666 shares of the healthcare conglomerate's stock, valued at approximately $88,862,000. UnitedHealth Group accounts for 2.1% of Nan Shan Life Insurance Co. Ltd.'s investment portfolio, making the stock its 9th largest position.

A number of other hedge funds also recently made changes to their positions in UNH. Western Pacific Wealth Management LP lifted its stake in UnitedHealth Group by 2.2% in the 4th quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate's stock worth $456,000 after purchasing an additional 19 shares in the last quarter. MCF Advisors LLC boosted its stake in UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate's stock worth $1,304,000 after acquiring an additional 20 shares in the last quarter. Axiom Financial Strategies LLC boosted its stake in UnitedHealth Group by 3.6% in the 4th quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate's stock worth $291,000 after purchasing an additional 20 shares in the last quarter. Richwood Investment Advisors LLC raised its position in UnitedHealth Group by 0.4% in the 4th quarter. Richwood Investment Advisors LLC now owns 5,247 shares of the healthcare conglomerate's stock worth $2,654,000 after buying an additional 20 shares during the last quarter. Finally, 44 Wealth Management LLC boosted its position in UnitedHealth Group by 1.6% in the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate's stock worth $662,000 after purchasing an additional 21 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on UNH shares. Truist Financial cut their price target on UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating for the company in a report on Monday, April 21st. Robert W. Baird cut their target price on shares of UnitedHealth Group from $640.00 to $510.00 and set an "outperform" rating for the company in a research note on Tuesday, April 29th. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Finally, KeyCorp decreased their price objective on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Four investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $596.86.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $311.23 on Wednesday. UnitedHealth Group Incorporated has a twelve month low of $309.10 and a twelve month high of $630.73. The business's 50-day moving average price is $482.53 and its two-hundred day moving average price is $519.28. The stock has a market cap of $282.33 billion, a P/E ratio of 20.08, a PEG ratio of 1.37 and a beta of 0.56. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter in the prior year, the company posted $6.91 earnings per share. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.70%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's payout ratio is presently 35.18%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.